全文获取类型
收费全文 | 376篇 |
免费 | 29篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 10篇 |
妇产科学 | 4篇 |
基础医学 | 22篇 |
口腔科学 | 5篇 |
临床医学 | 46篇 |
内科学 | 161篇 |
神经病学 | 32篇 |
特种医学 | 6篇 |
外科学 | 43篇 |
综合类 | 3篇 |
预防医学 | 20篇 |
眼科学 | 5篇 |
药学 | 25篇 |
中国医学 | 1篇 |
肿瘤学 | 20篇 |
出版年
2023年 | 3篇 |
2022年 | 3篇 |
2021年 | 14篇 |
2020年 | 14篇 |
2019年 | 3篇 |
2018年 | 7篇 |
2017年 | 6篇 |
2016年 | 6篇 |
2015年 | 11篇 |
2014年 | 20篇 |
2013年 | 16篇 |
2012年 | 41篇 |
2011年 | 34篇 |
2010年 | 16篇 |
2009年 | 10篇 |
2008年 | 26篇 |
2007年 | 20篇 |
2006年 | 26篇 |
2005年 | 23篇 |
2004年 | 44篇 |
2003年 | 25篇 |
2002年 | 20篇 |
2001年 | 1篇 |
1999年 | 5篇 |
1998年 | 3篇 |
1997年 | 1篇 |
1996年 | 2篇 |
1995年 | 1篇 |
1994年 | 2篇 |
1993年 | 1篇 |
1990年 | 1篇 |
1926年 | 1篇 |
排序方式: 共有406条查询结果,搜索用时 970 毫秒
1.
2.
Inflammation: the link between insulin resistance, obesity and diabetes 总被引:41,自引:0,他引:41
Recent data have revealed that the plasma concentration of inflammatory mediators, such as tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6), is increased in the insulin resistant states of obesity and type 2 diabetes, raising questions about the mechanisms underlying inflammation in these two conditions. It is also intriguing that an increase in inflammatory mediators or indices predicts the future development of obesity and diabetes. Two mechanisms might be involved in the pathogenesis of inflammation. Firstly, glucose and macronutrient intake causes oxidative stress and inflammatory changes. Chronic overnutrition (obesity) might thus be a proinflammatory state with oxidative stress. Secondly, the increased concentrations of TNF-alpha and IL-6, associated with obesity and type 2 diabetes, might interfere with insulin action by suppressing insulin signal transduction. This might interfere with the anti-inflammatory effect of insulin, which in turn might promote inflammation. 相似文献
3.
4.
5.
6.
Hui-Ling Kerr Edward Bayley Rosalyn Jackson Paresh Kothari 《Foot and Ankle Surgery》2013,19(4):273-275
BackgroundAnkle sprains are common, the majority resolving with functional rehabilitation. Some patients are left with symptoms of functional instability (FI). Ankle arthroscopy in those with symptoms of FI is not well covered in the literature. Our aim was to assess its role in FI of the ankle.MethodsRetrospective case note analysis of patients with FI following an ankle sprain from 2005 to 2007. All underwent arthroscopy, provided mechanical instability was excluded (EUA and stress X-rays), and there were no signs of soft tissue impingement. These patients had exhausted all options of conservative therapy.ResultsSeventy-seven patients with a mean age of 38.1: five had true mechanical instability and were excluded. 72 underwent arthroscopy: 67 (93.1%) had significant amounts of scar tissue needing debridement, most commonly in the antero-lateral corner (58.3%). 52 patients improved (72.2%) at a minimum of 6 months follow-up.ConclusionOur study supports the role of ankle arthroscopy in the treatment of FI following trauma. It should be considered when conservative measures have failed. 相似文献
7.
MD Zilberberg P Chaudhari BH Nathanson RS Campbell MF Emons S Fiske HD Hays AF Shorr 《BMC infectious diseases》2012,12(1):154
ABSTRACT: BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) is a frequent cause of complicated skin and skin structure infections (cSSSI). Patients with MRSA require different empiric treatment that those with non-MRSA infections, yet no accurate tools exist to aid in stratifying the risk for a MRSA cSSSI. Objectives. To develop a simple bedside decision rule to tailor empiric coverage more accurately. METHODS: We conducted a large multicenter (N=62 hospitals) retrospective cohort study in a US-based database between April 2005 and March 2009. All adult initial admissions with ICD-9-CM codes specific to cSSSI were included. Patients admitted with MRSA vs. non-MRSA were compared with regard to baseline demographic, clinical and hospital characteristics. We developed and validated a model to predict the risk of MRSA, and compared its performance via sensitivity, specificity and other classification statistics to the healthcare-associated (HCA) infection risk factors. RESULTS: Of the 7,183 patients with cSSSI, 2,387 (33.2%) had MRSA. Factors discriminating MRSA from non-MRSA were age, African-American race, no evidence of diabetes mellitus, cancer or renal dysfunction, and prior history of cardiac dysrhythmia. The score ranging from 0 to 8 points exhibited a consistent dose-response relationship. A MRSA score of 5 or higher was superior to the HCA classification in all characteristics, while that of 4 or higher was superior on all metrics except specificity. CONCLUSIONS: MRSA is present in 1/3 of all hospitalized cSSSI. A simple bedside risk score can help discriminate the risk for MRSA vs. other pathogens with improved accuracy compared to the HCA definition. 相似文献
8.
Ashok Kumar Sharma Hilal Al Sabti Paresh Kumar Kuba Jasvinder Sharma 《General thoracic and cardiovascular surgery》2014,62(4):262-265
A simple, safe, easily reproducible and quick method of taking lung biopsy in diffuse interstitial lung disease is described. 相似文献
9.
10.
Evidence for a potent antiinflammatory effect of rosiglitazone 总被引:35,自引:0,他引:35
Mohanty P Aljada A Ghanim H Hofmeyer D Tripathy D Syed T Al-Haddad W Dhindsa S Dandona P 《The Journal of clinical endocrinology and metabolism》2004,89(6):2728-2735
We have recently demonstrated a potent antiinflammatory effect of troglitazone, an agonist of peroxisome proliferator-activated receptor gamma (PPARgamma) and a partial agonist of PPARalpha in both the nondiabetic obese and diabetic obese subjects. We have now investigated the antiinflammatory actions of rosiglitazone, a selective PPARgamma agonist. Eleven nondiabetic obese subjects and 11 obese diabetic subjects were each given 4 mg of rosiglitazone daily for a period of 6 wk. Fasting blood samples were obtained at 0, 1, 2, 4, 6, and 12 wk (6 wk after the cessation of rosiglitazone). Eight obese subjects and five obese diabetic subjects were also included in the study as control groups. Fasting blood samples were obtained from the control groups at 0, 1, 2, 4, and 6 wk only. Nuclear factor kappaB (NFkappaB)-binding activity in mononuclear cells, plasma monocyte chemoattractant protein-1 (MCP-1), TNF-alpha, soluble intercellular adhesion molecule-1, C-reactive protein (CRP), and serum amyloid A (SAA) were measured. Blood glucose concentration changed significantly at 6 wk only in the obese diabetic subjects after rosiglitazone treatment for 6 wk, whereas insulin concentration decreased significantly at 6 wk in both groups. NFkappaB-binding activity in mononuclear cell nuclear extract fell in both obese and obese diabetic subjects (P < 0.02). Rosiglitazone treatment resulted in a reduction in plasma MCP-1 and CRP in both groups (P < 0.05). Plasma TNF-alpha and SAA concentrations were inhibited significantly in the obese group (P < 0.05) but not in the obese diabetic subjects. NFkappaB-binding activity and plasma MCP-1, CRP, SAA, and TNF-alpha did not change in the obese and obese diabetic control groups. We conclude that rosiglitazone, a selective PPARgamma agonist, exerts an antiinflammatory effect at the cellular and molecular level, and in plasma. These observations may have implications for atherogenesis in the long term in subjects treated with rosiglitazone and possibly other thiazolidinediones. 相似文献